Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HOME-PE2 : Home Treatment Versus Hospitalization in Patients With Acute Pulmonary Embolism, no Clinical Severity Criteria, and Either Right Ventricular Dysfunction or Elevated Troponin: a Randomized Controlled Trial

NCT07506291 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT07506291
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07506291 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HOME-PE2 : Home Treatment Versus Hospitalization in Patients With Acute Pulmonary Embolism, no Clinical Severity Criteria, and Either Right Ventricular Dysfunction or Elevated Troponin: a Randomized Controlled Trial
Lead sponsor
University Hospital, Angers
Phase
Not applicable
Overall status
Not yet recruiting
Start date
June 30, 2026
Completion date
September 30, 2029
Enrollment
568 (estimated)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

acute pulmonary embolism